A Phase II, Single Arm, Investigative Study of IMM-101 in Combination with Radiation Induced Tumour Necrosis in Patients with Previously Treated Colorectal Cancer.
Phase of Trial: Phase II
Latest Information Update: 04 Dec 2016
At a glance
- Drugs IMM 101 (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- Sponsors Immodulon Therapeutics
- 24 Sep 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 28 Jan 2014 Status changed from recruiting to active, no longer recruiting.
- 01 Mar 2012 New source identified and integrated (ClinicalTrials.gov NCT01539824).